FDA recall, , Moderate risk
American National Red Cross Red Blood Cells, Leukocytes Reduced, Irradiated
Red Blood Cells, Leukocytes Reduced, Irradiated were misbranded and distributed.
Recall ended Sep 22, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross, Lewis and Clark Region, began a recall of Red Blood Cells, Leukocytes Reduced, Irradiated on January 20, 2026, because the product was misbranded and distributed. The recall was added to the FDA's Enforcement Report and classified by the FDA on September 22, 2026, and in the FDA's weekly enforcement report on September 30, 2026. The product was distributed in Utah.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced, Irradiated
Recall details
- Company began the recall
- Sold in
- Company
- American National Red Cross (The), Lewis and Clark Region
- Hazard
- Mislabeled product
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99722
- Recall number
- B-0225-2026
All recalls from American National Red Cross (The), Lewis and Clark Region
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
